Mark Lawler

机构：Queen's University Belfast · ORCID：0000-0002-3930-8470

发表论文 553 篇 · 总被引 11591 次 · h-index 57

代表论文

• A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC) (2025 · BMC Cancer · 被引 5)
• Invisible geographies - the rural and coastal blind spot in UK cancer policy: A content analysis (2025 · Journal of Cancer Policy · 被引 4)
• Central and Eastern Europe: A crucible for clinical cancer innovation? (2025 · Journal of Cancer Policy · 被引 4)
• A new war on cancer? (2025 · The Lancet Oncology · 被引 4)
• Early cancer diagnosis is vital, but treatment delays are causing harm to patients (2025 · BMJ · 被引 4)
• Living within our means: trouble ahead for England's cancer planning (2025 · The Lancet Oncology · 被引 3)